Author
Listed:
- Johannes-Peter Stasch
(Pharma Research Center, Bayer AG)
- Eva Maria Becker
(Pharma Research Center, Bayer AG)
- Cristina Alonso-Alija
(Pharma Research Center, Bayer AG)
- Heiner Apeler
(Pharma Research Center, Bayer AG)
- Klaus Dembowsky
(Pharma Research Center, Bayer AG)
- Achim Feurer
(Pharma Research Center, Bayer AG)
- Rupert Gerzer
(DLR, Institute of Aerospace Medicine)
- Torsten Minuth
(Pharma Research Center, Bayer AG)
- Elisabeth Perzborn
(Pharma Research Center, Bayer AG)
- Ulrich Pleiß
(Pharma Research Center, Bayer AG)
- Henning Schröder
(Martin Luther University, School of Pharmacy)
- Werner Schroeder
(Pharma Research Center, Bayer AG)
- Elke Stahl
(Pharma Research Center, Bayer AG)
- Wolfram Steinke
(Pharma Research Center, Bayer AG)
- Alexander Straub
(Pharma Research Center, Bayer AG)
- Matthias Schramm
(Pharma Research Center, Bayer AG)
Abstract
Nitric oxide (NO) is a widespread, potent, biological mediator that has many physiological and pathophysiological roles1. Research in the field of NO appears to have followed a straightforward path, and the findings have been progressive: NO and cyclic GMP are involved in vasodilatation; glycerol trinitrate relaxes vascular smooth muscles by bioconversion to NO; mammalian cells synthesize NO; and last, NO mediates vasodilatation by stimulating the soluble guanylate cyclase (sGC), a heterodimeric (α/β) haem protein that converts GTP to cGMP2–4. Here we report the discovery of a regulatory site on sGC. Using photoaffinity labelling, we have identified the cysteine 238 and cysteine 243 region in the α1-subunit of sGC as the target for a new type of sGC stimulator. Moreover, we present a pyrazolopyridine, BAY 41-2272, that potently stimulates sGC through this site by a mechanism that is independent of NO. This results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and as such may offer an approach for treating cardiovascular diseases.
Suggested Citation
Johannes-Peter Stasch & Eva Maria Becker & Cristina Alonso-Alija & Heiner Apeler & Klaus Dembowsky & Achim Feurer & Rupert Gerzer & Torsten Minuth & Elisabeth Perzborn & Ulrich Pleiß & Henning Schröde, 2001.
"NO-independent regulatory site on soluble guanylate cyclase,"
Nature, Nature, vol. 410(6825), pages 212-215, March.
Handle:
RePEc:nat:nature:v:410:y:2001:i:6825:d:10.1038_35065611
DOI: 10.1038/35065611
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:410:y:2001:i:6825:d:10.1038_35065611. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.